CLINICAL_TRIALS
trial_result
· 2021-07-28
Clinical Trial Update: 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression [Phase 2]
Summary
A Phase 2 trial evaluating adjunctive infliximab for bipolar depression has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Bipolar Depression | Phase 2 | Status: COMPLETED | Results posted: 2021-07-28